Clinical Trial Update: Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating ranibizumab to treat rubeosis iridis in diabetics before cataract surgery, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy
• Rubeosis Iridis

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Bhagat, Neelakshi, M.D., M.P.H. | Conditions: Rubeosis Iridis, Proliferative Diabetic Retinopathy | Phase 1 | Status: COMPLETED | Results posted: 2012-10-04